SPALLUTO, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 3.522
AS - Asia 2.014
EU - Europa 964
SA - Sud America 279
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 3
Totale 6.829
Nazione #
US - Stati Uniti d'America 3.435
SG - Singapore 674
CN - Cina 593
BR - Brasile 203
VN - Vietnam 199
UA - Ucraina 187
DE - Germania 185
HK - Hong Kong 165
TR - Turchia 158
GB - Regno Unito 137
SE - Svezia 85
IT - Italia 78
FI - Finlandia 73
FR - Francia 66
IN - India 57
JP - Giappone 47
CA - Canada 41
RU - Federazione Russa 40
BD - Bangladesh 38
MX - Messico 33
AR - Argentina 30
PL - Polonia 27
ES - Italia 20
ZA - Sudafrica 18
AT - Austria 15
IQ - Iraq 15
NL - Olanda 14
EC - Ecuador 11
CO - Colombia 8
LT - Lituania 8
SA - Arabia Saudita 8
BE - Belgio 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
JO - Giordania 6
MA - Marocco 6
PK - Pakistan 6
BO - Bolivia 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
JM - Giamaica 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
IR - Iran 3
MY - Malesia 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
CR - Costa Rica 2
CY - Cipro 2
GT - Guatemala 2
GY - Guiana 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
PH - Filippine 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 6.812
Città #
Singapore 436
Ashburn 312
Woodbridge 272
Chandler 251
San Jose 236
Houston 228
Fairfield 204
Jacksonville 198
Beijing 194
Hong Kong 165
Ann Arbor 164
Santa Clara 148
Nanjing 87
Wilmington 85
Dallas 77
Izmir 76
Ho Chi Minh City 67
Seattle 66
Los Angeles 64
Cambridge 53
Council Bluffs 50
New York 50
Munich 49
Hanoi 47
Princeton 46
Tokyo 37
Boardman 35
Dearborn 35
Lauterbourg 27
Shanghai 26
Orem 23
São Paulo 23
Buffalo 22
London 22
Shenyang 22
Turku 21
Milan 19
Nanchang 19
Warsaw 19
Brooklyn 18
Mexico City 18
Hefei 17
San Diego 17
Tianjin 17
Frankfurt am Main 16
Toronto 15
Addison 14
Chennai 14
Falkenstein 14
Helsinki 14
San Mateo 14
Vienna 14
Changsha 13
San Francisco 12
Atlanta 11
Jiaxing 11
Da Nang 10
Hebei 10
Phoenix 10
Chicago 9
Jinan 9
Johannesburg 9
Moscow 9
Rio de Janeiro 9
Zhengzhou 9
Bremen 8
Falls Church 8
Kunming 8
Manchester 8
Mumbai 8
Norwalk 8
Ottawa 8
Philadelphia 8
Poplar 8
Amsterdam 7
Boston 7
Ningbo 7
Taizhou 7
Amman 6
Brussels 6
Ferrara 6
Haiphong 6
Montreal 6
Rome 6
Charlotte 5
Denver 5
Louisville 5
Verona 5
Ankara 4
Baghdad 4
Biên Hòa 4
Bắc Ninh 4
City of London 4
Columbus 4
Delhi 4
Dublin 4
Hải Dương 4
Istanbul 4
Milwaukee 4
Olomouc 4
Totale 4.512
Nome #
4-Isopropyl-2-oxazolin-5-one anion as a new convenient formyl anion equivalent for conjugate addition and aldol reactions 329
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 276
4-Isopropyl-2-oxazolin-5-one anion as masked umpoled synthon for both formyl and hydroxycarbonyl anions: generation, reactivity and synthetic applications 262
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 256
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 243
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 243
5‐Hydroxytryptamine‐mediated effects of nicotine on endogenous GABA efflux from guinea‐pig cortical slices 242
Mastering β-Keto Esters 238
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 225
Alpha-2 adrenoreceptor-mediated decrease in gamma-aminobutyric acid outflow in cortical slices and synaptosomes during morphine tolerance 219
Effect of acute and subchronic nicotine treatment on cortical efflux of [3H]‐d‐aspartate and endogenous GABA in freely moving guinea‐pigs 218
A new synthetic approach to indazole synthesis 214
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 213
Alpha-1 adrenoreceptor-mediated increase in ACh release in brain slices during morphine tolerance 211
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 208
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 199
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 194
Generation and cycloaddition reactions of 3-substituted-2-nitro-1,3- dienes 184
New potent and selective human adenosine A3 receptor antagonists 181
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 180
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 178
Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies 147
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 139
Pharmacological and biochemical characterization of A3 adenosine receptor in Jurkat T cells. 137
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 126
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 125
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 122
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 121
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 119
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 117
Pyrazolo[4,3-e]1,2,4-triazolo[1,5]pyrimidine derivates as irreversible antagonists at the human A3 adenosine receptor 116
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor 116
Synthesis and preliminary biological evaluation of [3H]-MRE 3008F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors 115
Synthesis, biological properties and molecular modelling investigation of the first potent, selective and water soluble human A3 adenosine receptor antagonist. 115
Pyrazolo-triazolo-pyrimidine as human A3 adenosine receptor antagonists: influence of the substitutent at N8 pyrazole nucleus. 107
Pyrazolo-triazolo-pyrimidine derivates as adenosine receptor ligands: a search for A2B adenosine receptor antagonists. 106
Pyrazolo [4,3-E]1,2,4-trazolo[1,5-c]pyrimidine derivatives a new class of potent and selective human A3 adenosine receptor antagonists 102
Second generation of A2A adenosine receptor antagonist: synthesis and biological evaluation 97
An efficient synthesis of 4-oxo-2,5-hexadienoates via Δ2-isoxazoline intermediates 89
Totale 6.829
Categoria #
all - tutte 29.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022386 0 42 19 27 20 11 11 22 17 33 46 138
2022/2023488 41 44 6 78 82 74 16 50 63 2 18 14
2023/2024198 22 26 10 5 27 26 8 12 5 3 1 53
2024/2025902 15 24 66 54 98 74 28 49 115 116 129 134
2025/20262.585 288 91 220 380 397 188 229 108 259 289 94 42
2026/2027145 71 74 0 0 0 0 0 0 0 0 0 0
Totale 6.829